Exact Mass: 529.038618

Exact Mass Matches: 529.038618

Found 21 metabolites which its exact mass value is equals to given mass value 529.038618, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

dTDP-3-amino-2,3,6-trideoxy-D-threo-hexopyranos-4-ulose

dTDP-3-amino-2,3,6-trideoxy-4-keto-D-glucose; dTDP-3-amino-2,3,6-trideoxy-D-threo-hexopyranos-4-ulose; dTDP-3-amino-4-oxo-2,3,6-trideoxy-D-glucose

C16H25N3O13P2 (529.086258)


   

dTDP-3-amino-4,6-deoxy-3,4-dehydroglucose

dTDP-3-amino-4,6-dideoxy-3,4-dehydroglucose

C16H25N3O13P2 (529.086258)


   

dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose

dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose

C16H25N3O13P2 (529.086258)


   

Dragmacidin E

(-)-Dragmacidin E

C25H20BrN7O2 (529.086176)


   

CHEMBL1185318

CHEMBL1185318

C25H20BrN7O2 (529.086176)


   

2-Hydroxytenoxicam glucuronide

2-Hydroxytenoxicam glucuronide

C19H19N3O11S2 (529.0460984)


   

Hydroxytenoxicam glucuronide

Hydroxytenoxicam glucuronide

C19H19N3O11S2 (529.0460984)


   

Fmoc-D-Tyr(3-I)-OH

Fmoc-D-Tyr(3-I)-OH

C24H20INO5 (529.038618)


   

Fmoc-Tyr(3-I)-OH

Fmoc-Tyr(3-I)-OH

C24H20INO5 (529.038618)


   

Lithium guanosine triphosphate

Lithium guanosine triphosphate

C10H15LiN5O14P3 (528.9988430000001)


   

Flubrocythrinate

Flubrocythrinate

C26H22BrF2NO4 (529.0700176)


   

CDP-3,6-dideoxy-D-glycero-D-glycero-4-hexulose

CDP-3,6-dideoxy-D-glycero-D-glycero-4-hexulose

C15H21N3O14P2-2 (529.0498746000001)


   

N5-CDP-L-glutamine

N5-CDP-L-glutamine

C14H21N5O13P2-2 (529.0611076)


   

CDP-3,6-dideoxy-D-glycero-4-hexulose

CDP-3,6-dideoxy-D-glycero-4-hexulose

C15H21N3O14P2-2 (529.0498746000001)


   

[[3-(2-Amino-7,8-dihydroxy-4-oxo-3,5,6,7-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy]-hydroxyphosphoryl] phosphono hydrogen phosphate

[[3-(2-Amino-7,8-dihydroxy-4-oxo-3,5,6,7-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy]-hydroxyphosphoryl] phosphono hydrogen phosphate

C9H18N5O15P3 (529.0012268)


   

[(2R,4S,6S)-4-amino-6-methyl-5-oxooxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

[(2R,4S,6S)-4-amino-6-methyl-5-oxooxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

C16H25N3O13P2 (529.086258)


   

2-({2-[Benzyl-(4-bromo-benzenesulfonyl)-amino]-acetyl}-hydrazonomethyl)-benzoic acid

2-({2-[Benzyl-(4-bromo-benzenesulfonyl)-amino]-acetyl}-hydrazonomethyl)-benzoic acid

C23H20BrN3O5S (529.030697)


   

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-[2-(methylthio)-4-pyrimidinyl]-2-thiophenesulfonamide

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-[2-(methylthio)-4-pyrimidinyl]-2-thiophenesulfonamide

C18H13F6N3O3S3 (529.0023219999999)


   

CDP-4-dehydro-3,6-dideoxy-D-glucose(2-)

CDP-4-dehydro-3,6-dideoxy-D-glucose(2-)

C15H21N3O14P2-2 (529.0498746000001)


   

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-bromobenzoate

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-bromobenzoate

C17H17BrN5O8P (528.9998072)


   

Nebentan (potassium)

Nebentan (potassium)

C24H20KN5O5S (529.082217)


Nebentan potassium (YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan (HY-A0013). Nebentan potassium inhibits [125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively[1]. YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo[2].